Literature DB >> 13125202

Physico-chemical study of human isohaemagglutination.

S FILITTI-WURMSER, Y JACQUOT-ARMAND, G AUBEL-LESURE, R WURMSER.   

Abstract

Entities:  

Keywords:  HEMAGGLUTINATION

Mesh:

Year:  1954        PMID: 13125202     DOI: 10.1111/j.1469-1809.1952.tb02511.x

Source DB:  PubMed          Journal:  Ann Eugen


× No keyword cloud information.
  9 in total

1.  REACTION OF 7S AND 19S COMPONENTS OF IMMUNE RABBIT ANTISERA WITH HUMAN GROUP A AND AB RED CELLS.

Authors:  C L GREENBURY; D H MOORE; L A NUNN
Journal:  Immunology       Date:  1963-09       Impact factor: 7.397

2.  The kinetics of the reaction between the blood-group antibody anti-c and erythrocytes.

Authors:  N C HUGHES-JONES; B GARDNER; R TELFORD
Journal:  Biochem J       Date:  1962-12       Impact factor: 3.857

3.  The phosphate partition of the erythrocytes of normal newborn infants and of infants with hemolytic disease.

Authors:  V E AYERS; T J GREENWALT
Journal:  J Clin Invest       Date:  1956-12       Impact factor: 14.808

4.  [Not Available].

Authors:  B Gibb; R Giebelmann; S Martin; F Martin; M Schulz; H G Lippmann
Journal:  Diabetologia       Date:  1966-04       Impact factor: 10.122

5.  [Is the distinction of genotypes of blood group A possible with the aid of thermodynamic properties?].

Authors:  I Oepen
Journal:  Humangenetik       Date:  1968

6.  Quantitative hemagglutination in the ABO system.

Authors:  H W Hunt; N E Morton
Journal:  Am J Hum Genet       Date:  1969-01       Impact factor: 11.025

7.  A new approach to the thermodynamic study of ABO antibodies.

Authors:  P Rouger; C Salmon
Journal:  Immunology       Date:  1979-07       Impact factor: 7.397

8.  [On the question of the glomerular permeation of high molecular weight proteins].

Authors:  H G Lippmann; S Martin; M Schulz
Journal:  Experientia       Date:  1965-11-15

9.  VISUALIZATION OF ANTIGENIC SITES OF HUMAN ERYTHROCYTES WITH FERRITIN-ANTIBODY CONJUGATES.

Authors:  R E LEE; J D FELDMAN
Journal:  J Cell Biol       Date:  1964-11       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.